KEGG   Otolemur garnettii (small-eared galago): 100942002
Entry
100942002         CDS       T07855                                 
Symbol
IL2
Name
(RefSeq) interleukin-2
  KO
K05429  interleukin 2
Organism
oga  Otolemur garnettii (small-eared galago)
Pathway
oga04060  Cytokine-cytokine receptor interaction
oga04061  Viral protein interaction with cytokine and cytokine receptor
oga04151  PI3K-Akt signaling pathway
oga04625  C-type lectin receptor signaling pathway
oga04630  JAK-STAT signaling pathway
oga04658  Th1 and Th2 cell differentiation
oga04659  Th17 cell differentiation
oga04660  T cell receptor signaling pathway
oga04672  Intestinal immune network for IgA production
oga04940  Type I diabetes mellitus
oga05135  Yersinia infection
oga05142  Chagas disease
oga05162  Measles
oga05166  Human T-cell leukemia virus 1 infection
oga05171  Coronavirus disease - COVID-19
oga05200  Pathways in cancer
oga05320  Autoimmune thyroid disease
oga05321  Inflammatory bowel disease
oga05330  Allograft rejection
oga05332  Graft-versus-host disease
Brite
KEGG Orthology (KO) [BR:oga00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04630 JAK-STAT signaling pathway
    100942002 (IL2)
   04151 PI3K-Akt signaling pathway
    100942002 (IL2)
  09133 Signaling molecules and interaction
   04060 Cytokine-cytokine receptor interaction
    100942002 (IL2)
   04061 Viral protein interaction with cytokine and cytokine receptor
    100942002 (IL2)
 09150 Organismal Systems
  09151 Immune system
   04625 C-type lectin receptor signaling pathway
    100942002 (IL2)
   04660 T cell receptor signaling pathway
    100942002 (IL2)
   04658 Th1 and Th2 cell differentiation
    100942002 (IL2)
   04659 Th17 cell differentiation
    100942002 (IL2)
   04672 Intestinal immune network for IgA production
    100942002 (IL2)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    100942002 (IL2)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    100942002 (IL2)
   05171 Coronavirus disease - COVID-19
    100942002 (IL2)
   05162 Measles
    100942002 (IL2)
  09171 Infectious disease: bacterial
   05135 Yersinia infection
    100942002 (IL2)
  09174 Infectious disease: parasitic
   05142 Chagas disease
    100942002 (IL2)
  09163 Immune disease
   05320 Autoimmune thyroid disease
    100942002 (IL2)
   05321 Inflammatory bowel disease
    100942002 (IL2)
   05330 Allograft rejection
    100942002 (IL2)
   05332 Graft-versus-host disease
    100942002 (IL2)
  09167 Endocrine and metabolic disease
   04940 Type I diabetes mellitus
    100942002 (IL2)
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04052 Cytokines and neuropeptides [BR:oga04052]
    100942002 (IL2)
   00536 Glycosaminoglycan binding proteins [BR:oga00536]
    100942002 (IL2)
Cytokines and neuropeptides [BR:oga04052]
 Cytokines
  Interleukins
   100942002 (IL2)
Glycosaminoglycan binding proteins [BR:oga00536]
 Heparan sulfate / Heparin
  Cytokines
   100942002 (IL2)
SSDB
Motif
Pfam: IL2 IL15
Other DBs
NCBI-GeneID: 100942002
NCBI-ProteinID: XP_003795566
Ensembl: ENSOGAG00000033865
UniProt: H0Y254
LinkDB
Position
Unknown
AA seq 152 aa
MYKMQLLTCIALTFALVTNSAPISSSTKETRQQLEQLLLDLQMVLNGVNNNKNPKLSRML
TLKLYVPKKATELKHLQCLEEELGPLEKVLDLGQSKNFHLGDTREVIGNINVTVLELKGS
ETFICEDNETATIVEFLNRWITFCQSIISTMT
NT seq 459 nt   +upstreamnt  +downstreamnt
atgtacaagatgcaactcttgacttgcattgcactaacttttgcccttgtcacaaacagt
gcacctatttcaagctctacaaaggaaacacggcaacaactggagcaattactgctagat
ttacagatggttttgaatggcgttaataataacaagaatcccaaactctccaggatgctc
acacttaaattatatgtgcccaagaaggccacagaattgaaacatcttcaatgcctagaa
gaagaacttggacctctggagaaagtgctagatttaggtcaaagcaaaaactttcacttg
ggagataccagggaagtaattggcaatatcaatgtaacggttctggaactaaagggatct
gaaacattcatatgtgaagataatgagacagcaaccattgtagaatttctgaacagatgg
attaccttttgtcaaagcatcatctcaacaatgacttga

DBGET integrated database retrieval system